A pilot open label trial of HIV therapy with d4T (stavudine), ddI (didanosine), nelfinavir and hydroxyurea [hydroxycarbamide] in subjects with recent HIV infection

Trial Profile

A pilot open label trial of HIV therapy with d4T (stavudine), ddI (didanosine), nelfinavir and hydroxyurea [hydroxycarbamide] in subjects with recent HIV infection

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 19 Dec 2006

At a glance

  • Drugs Didanosine; Hydroxycarbamide; Nelfinavir; Stavudine
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Dec 2006 Status change
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top